Year |
Citation |
Score |
2020 |
Ferri M, Alunno M, Greco FA, Mammoli A, Saluti G, Carotti A, Sardella R, Macchiarulo A, Camaioni E, Liscio P. Fragment based drug design and diversity-oriented synthesis of carboxylic acid isosteres. Bioorganic & Medicinal Chemistry. 28: 115731. PMID 33007550 DOI: 10.1016/J.Bmc.2020.115731 |
0.308 |
|
2020 |
Mammoli A, Coletti A, Ballarotto M, Riccio A, Carotti A, Grohmann U, Camaioni E, Macchiarulo A. New Insights from Crystallographic Data: Diversity of Structural Motifs and Molecular Recognition Properties between Groups of IDO1 Structures. Chemmedchem. PMID 32190988 DOI: 10.1002/Cmdc.202000116 |
0.326 |
|
2020 |
Cerra B, Macchiarulo A, Carotti A, Camaioni E, Varfaj I, Sardella R, Gioiello A. Enantioselective HPLC Analysis to Assist the Chemical Exploration of Chiral Imidazolines. Molecules (Basel, Switzerland). 25. PMID 32024219 DOI: 10.3390/Molecules25030640 |
0.305 |
|
2018 |
Buonvicino D, Mazzola F, Zamporlini F, Resta F, Ranieri G, Camaioni E, Muzzi M, Zecchi R, Pieraccini G, Dölle C, Calamante M, Bartolucci G, Ziegler M, Stecca B, Raffaelli N, et al. Identification of the Nicotinamide Salvage Pathway as a New Toxification Route for Antimetabolites. Cell Chemical Biology. PMID 29478906 DOI: 10.1016/J.Chembiol.2018.01.012 |
0.311 |
|
2017 |
Coletti A, Greco FA, Dolciami D, Camaioni E, Sardella R, Pallotta MT, Volpi C, Orabona C, Grohmann U, Macchiarulo A. Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry. Medchemcomm. 8: 1378-1392. PMID 30108849 DOI: 10.1039/C7Md00109F |
0.327 |
|
2017 |
Carotti A, Ianni F, Camaioni E, Pucciarini L, Marinozzi M, Sardella R, Natalini B. N-Decyl-S-trityl-(R)-cysteine, a new chiral selector for "green" ligand-exchange chromatography applications. Journal of Pharmaceutical and Biomedical Analysis. PMID 28209350 DOI: 10.1016/J.Jpba.2017.02.009 |
0.319 |
|
2014 |
Liscio P, Carotti A, Asciutti S, Ferri M, Pires MM, Valloscuro S, Ziff J, Clark NR, Macchiarulo A, Aaronson SA, Pellicciari R, Camaioni E. Scaffold hopping approach on the route to selective tankyrase inhibitors. European Journal of Medicinal Chemistry. 87: 611-23. PMID 25299683 DOI: 10.1016/J.Ejmech.2014.10.007 |
0.344 |
|
2014 |
Marchand JR, Carotti A, Passeri D, Filipponi P, Liscio P, Camaioni E, Pellicciari R, Gioiello A, Macchiarulo A. Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy. Biochimica Et Biophysica Acta. 1844: 1765-72. PMID 25062913 DOI: 10.1016/J.Bbapap.2014.07.012 |
0.318 |
|
2014 |
Liscio P, Carotti A, Asciutti S, Karlberg T, Bellocchi D, Llacuna L, Macchiarulo A, Aaronson SA, Schüler H, Pellicciari R, Camaioni E. Design, synthesis, crystallographic studies, and preliminary biological appraisal of new substituted triazolo[4,3-b]pyridazin-8-amine derivatives as tankyrase inhibitors. Journal of Medicinal Chemistry. 57: 2807-12. PMID 24527792 DOI: 10.1021/Jm401356T |
0.371 |
|
2014 |
Antonyan A, De A, Vitali LA, Pettinari R, Marchetti F, Gigliobianco MR, Pettinari C, Camaioni E, Lupidi G. Evaluation of (arene)Ru(II) complexes of curcumin as inhibitors of dipeptidyl peptidase IV. Biochimie. 99: 146-52. PMID 24316375 DOI: 10.1016/J.Biochi.2013.11.021 |
0.323 |
|
2013 |
Liscio P, Camaioni E, Carotti A, Pellicciari R, Macchiarulo A. From polypharmacology to target specificity: the case of PARP inhibitors. Current Topics in Medicinal Chemistry. 13: 2939-54. PMID 24171773 DOI: 10.2174/15680266113136660209 |
0.317 |
|
2013 |
Antolin AA, Carotti A, Nuti R, Hakkaya A, Camaioni E, Mestres J, Pellicciari R, Macchiarulo A. Exploring the effect of PARP-1 flexibility in docking studies. Journal of Molecular Graphics & Modelling. 45: 192-201. PMID 24056306 DOI: 10.1016/J.Jmgm.2013.08.006 |
0.342 |
|
2013 |
Ekblad T, Camaioni E, Schüler H, Macchiarulo A. PARP inhibitors: polypharmacology versus selective inhibition. The Febs Journal. 280: 3563-75. PMID 23601167 DOI: 10.1111/Febs.12298 |
0.33 |
|
2012 |
Lupidi G, Camaioni E, Khalifé H, Avenali L, Damiani E, Tanfani F, Scirè A. Characterization of thymoquinone binding to human α₁-acid glycoprotein. Journal of Pharmaceutical Sciences. 101: 2564-73. PMID 22467430 DOI: 10.1002/Jps.23138 |
0.306 |
|
2011 |
Natalini B, Sardella R, Gioiello A, Rosatelli E, Ianni F, Camaioni E, Pellicciari R. Fast chromatographic determination of the bile salt critical micellar concentration. Analytical and Bioanalytical Chemistry. 401: 267-74. PMID 21573726 DOI: 10.1007/S00216-011-5082-4 |
0.344 |
|
2011 |
Pellicciari R, Camaioni E, Gilbert AM, Macchiarulo A, Bikker JA, Shah F, Bard J, Costantino G, Gioiello A, Robertson GM, Sabbatini P, Venturoni F, Liscio P, Carotti A, Bellocchi D, et al. Discovery and characterization of novel potent PARP-1 inhibitors endowed with neuroprotective properties: From TIQ-A to HYDAMTIQ Medchemcomm. 2: 559-565. DOI: 10.1039/C1Md00021G |
0.359 |
|
2010 |
Cristalli G, Costanzi S, Lambertucci C, Lupidi G, Vittori S, Volpini R, Camaioni E. ChemInform Abstract: Adenosine Deaminase: Functional Implications and Different Classes of Inhibitors Cheminform. 32: no-no. DOI: 10.1002/CHIN.200122256 |
0.539 |
|
2010 |
Volpini R, Camaioni E, Costanzi S, Vittori S, Klotz K, Cristalli G. ChemInform Abstract: Synthesis of Di- and Trisubstituted Adenosine Derivatives (V) and (VIII) and Their Affinities at Human Adenosine Receptor Subtypes. Cheminform. 31: no-no. DOI: 10.1002/CHIN.200016235 |
0.609 |
|
2010 |
Vittori S, Camaioni E, Constanzi S, Volpini R, Klotz K, Cristalli G. ChemInform Abstract: Synthesis and Receptor Affinity of Polysubstituted Adenosines Cheminform. 30: no-no. DOI: 10.1002/CHIN.199942250 |
0.32 |
|
2010 |
Vittori S, Camaioni E, Costanzi S, Volpini R, Cristalli G. ChemInform Abstract: Coupling of 2,6-Dichloropurine and 2,6-Dichlorodeazapurines with Ribose and Ribose Modified Sugars Cheminform. 30: no-no. DOI: 10.1002/CHIN.199941217 |
0.503 |
|
2010 |
Volpini R, Camaioni E, Costanzi S, Vittori S, Cristalli G. ChemInform Abstract: Synthesis of New 3′-Deoxyribonucleosides Employing the Acid-Catalyzed Fusion Method. Cheminform. 30: no-no. DOI: 10.1002/CHIN.199916238 |
0.527 |
|
2009 |
Natalini B, Sardella R, Camaioni E, Macchiarulo A, Gioiello A, Carbone G, Pellicciari R. Derived chromatographic indices as effective tools to study the self-aggregation process of bile acids. Journal of Pharmaceutical and Biomedical Analysis. 50: 613-21. PMID 19081222 DOI: 10.1016/J.Jpba.2008.10.035 |
0.302 |
|
2009 |
Macchiarulo A, Camaioni E, Nuti R, Pellicciari R. Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease. Amino Acids. 37: 219-29. PMID 18612775 DOI: 10.1007/S00726-008-0137-3 |
0.302 |
|
2008 |
Pellicciari R, Camaioni E, Costantino G, Formentini L, Sabbatini P, Venturoni F, Eren G, Bellocchi D, Chiarugi A, Moroni F. On the way to selective PARP-2 inhibitors. Design, synthesis, and preliminary evaluation of a series of isoquinolinone derivatives. Chemmedchem. 3: 914-23. PMID 18409175 DOI: 10.1002/Cmdc.200800010 |
0.357 |
|
2007 |
Macchiarulo A, Nuti R, Bellocchi D, Camaioni E, Pellicciari R. Molecular docking and spatial coarse graining simulations as tools to investigate substrate recognition, enhancer binding and conformational transitions in indoleamine-2,3-dioxygenase (IDO). Biochimica Et Biophysica Acta. 1774: 1058-68. PMID 17644054 DOI: 10.1016/J.Bbapap.2007.06.007 |
0.316 |
|
2004 |
Pellicciari R, Costantino G, Camaioni E, Sadeghpour BM, Entrena A, Willson TM, Fiorucci S, Clerici C, Gioiello A. Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid. Journal of Medicinal Chemistry. 47: 4559-69. PMID 15317466 DOI: 10.1021/Jm049904B |
0.406 |
|
2004 |
Costantino G, Marinozzi M, Camaioni E, Natalini B, Sarichelou I, Micheli F, Cavanni P, Faedo S, Noe C, Moroni F, Pellicciari R. Stereoselective synthesis and preliminary evaluation of (+)- and (-)-3-methyl-5-carboxy-thien-2-yl-glycine (3-MATIDA): identification of (+)-3-MATIDA as a novel mGluR1 competitive antagonist. Farmaco (Societã Chimica Italiana : 1989). 59: 93-9. PMID 14871500 DOI: 10.1016/J.Farmac.2003.11.008 |
0.386 |
|
2003 |
Traversa U, Bombi G, Camaioni E, Macchiarulo A, Costantino G, Palmieri C, Caciagli F, Pellicciari R. Rat brain guanosine binding site. Biological studies and pseudo-receptor construction. Bioorganic & Medicinal Chemistry. 11: 5417-25. PMID 14642586 DOI: 10.1016/J.Bmc.2003.09.043 |
0.393 |
|
2003 |
Pellicciari R, Camaioni E, Costantino G, Marinozzi M, Macchiarulo A, Moroni F, Natalini B. Towards new neuroprotective agents: design and synthesis of 4H-thieno[2,3-c] isoquinolin-5-one derivatives as potent PARP-1 inhibitors. Farmaco (Societã Chimica Italiana : 1989). 58: 851-8. PMID 13679179 DOI: 10.1016/S0014-827X(03)00143-5 |
0.383 |
|
2003 |
Costantino G, Macchiarulo A, Entrena-Guadix A, Camaioni E, Pellicciari R. Binding mode of 6ECDCA, a potent bile acid agonist of the farnesoid X receptor (FXR). Bioorganic & Medicinal Chemistry Letters. 13: 1865-8. PMID 12749886 DOI: 10.1016/S0960-894X(03)00281-6 |
0.371 |
|
2003 |
Chiarugi A, Meli E, Calvani M, Picca R, Baronti R, Camaioni E, Costantino G, Marinozzi M, Pellegrini-Giampietro DE, Pellicciari R, Moroni F. Novel isoquinolinone-derived inhibitors of poly(ADP-ribose) polymerase-1: pharmacological characterization and neuroprotective effects in an in vitro model of cerebral ischemia. The Journal of Pharmacology and Experimental Therapeutics. 305: 943-9. PMID 12606624 DOI: 10.1124/Jpet.103.048934 |
0.35 |
|
2002 |
Pellicciari R, Fiorucci S, Camaioni E, Clerici C, Costantino G, Maloney PR, Morelli A, Parks DJ, Willson TM. 6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. Journal of Medicinal Chemistry. 45: 3569-72. PMID 12166927 DOI: 10.1021/Jm025529G |
0.354 |
|
2001 |
Costantino G, Macchiarulo A, Camaioni E, Pellicciari R. Modeling of poly(ADP-ribose)polymerase (PARP) inhibitors. Docking of ligands and quantitative structure-activity relationship analysis. Journal of Medicinal Chemistry. 44: 3786-94. PMID 11689065 DOI: 10.1021/Jm010116L |
0.377 |
|
2001 |
Pellicciari R, Costantino G, Marinozzi M, Macchiarulo A, Camaioni E, Natalini B. Metabotropic glutamate receptors: structure and new subtype-selective ligands. Farmaco (Societã Chimica Italiana : 1989). 56: 91-4. PMID 11347974 DOI: 10.1016/S0014-827X(01)01006-0 |
0.385 |
|
2001 |
Costantino G, Maltoni K, Marinozzi M, Camaioni E, Prezeau L, Pin JP, Pellicciari R. Synthesis and biological evaluation of 2-(3'-(1H-tetrazol-5-yl) bicyclo[1.1.1]pent-1-yl)glycine (S-TBPG), a novel mGlu1 receptor antagonist. Bioorganic & Medicinal Chemistry. 9: 221-7. PMID 11249114 DOI: 10.1016/S0968-0896(00)00270-4 |
0.393 |
|
2001 |
Cristalli G, Costanzi S, Lambertucci C, Lupidi G, Vittori S, Volpini R, Camaioni E. Adenosine deaminase: functional implications and different classes of inhibitors. Medicinal Research Reviews. 21: 105-28. PMID 11223861 DOI: 10.1002/1098-1128(200103)21:2<105::Aid-Med1002>3.0.Co;2-U |
0.578 |
|
2000 |
Ziganshin AU, Zaitsev AP, Zaitseva IP, Kim YC, Camaioni E, Burnstock G, Jacobson KA. EFFECT OF NEW PYRIDOXAL PHOSPHATE ARYLAZO DERIVATIVES ON THE ECTO-ATPase ACTIVITY IN GUINEA PIG TISSUES. Pharmaceutical Chemistry Journal. 34: 226-228. PMID 31824124 DOI: 10.1007/Bf02524624 |
0.431 |
|
2000 |
Volpini R, Camaioni E, Costanzi S, Vittori S, Klotz KN, Cristalli G. Synthesis of di- and tri-substituted adenosine derivatives and their affinities at human adenosine receptor subtypes. Nucleosides & Nucleotides. 18: 2511-20. PMID 10639752 DOI: 10.1080/07328319908044623 |
0.659 |
|
1999 |
Jacobson KA, Hoffmann C, Kim YC, Camaioni E, Nandanan E, Jang SY, Guo DP, Ji XD, von Kügelgen I, Moro S, Ziganshin AU, Rychkov A, King BF, Brown SG, Wildman SS, et al. Molecular recognition in P2 receptors: ligand development aided by molecular modeling and mutagenesis. Progress in Brain Research. 120: 119-32. PMID 10550992 DOI: 10.1016/S0079-6123(08)63550-5 |
0.729 |
|
1999 |
Klotz KN, Camaioni E, Volpini R, Kachler S, Vittori S, Cristalli G. 2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A3 adenosine receptors. Naunyn-Schmiedeberg's Archives of Pharmacology. 360: 103-8. PMID 10494877 DOI: 10.1007/S002109900044 |
0.436 |
|
1999 |
Vittori S, Camaioni E, Costanzi S, Volpini R, Klotz KN, Cristalli G. Synthesis and receptor affinity of polysubstituted adenosines. Nucleosides & Nucleotides. 18: 739-40. PMID 10432676 DOI: 10.1080/15257779908041560 |
0.643 |
|
1999 |
Nandanan E, Camaioni E, Jang SY, Kim YC, Cristalli G, Herdewijn P, Secrist JA, Tiwari KN, Mohanram A, Harden TK, Boyer JL, Jacobson KA. Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists. Journal of Medicinal Chemistry. 42: 1625-38. PMID 10229631 DOI: 10.1021/Jm980657J |
0.653 |
|
1999 |
Barbieri D, Franceschi C, Camaioni E, Costanzi S, Vittori S, Volpini R, Cristalli G. Modulation of apoptosis in human lymphocytes by adenosine analogues. Bioorganic & Medicinal Chemistry Letters. 8: 2533-8. PMID 9873575 DOI: 10.1016/S0960-894X(98)00452-1 |
0.563 |
|
1999 |
Vittori S, Camaioni E, Costanzi S, Volpini R, Lupidi G, Cristalli G. Structure-Activity Relationships of Adenosine Deaminase Inhibitors Nucleosides and Nucleotides. 18: 741-742. DOI: 10.1080/15257779908041561 |
0.627 |
|
1999 |
Vittori S, Camaioni E, Costanzi S, Volpini R, Cristalli G. Coupling of 2,6-Dichloropurine and 2,6-Dichlorodeazapurines with Ribose and Ribose Modified Sugars Nucleosides and Nucleotides. 18: 587-590. DOI: 10.1080/15257779908041503 |
0.59 |
|
1998 |
Kim YC, Camaioni E, Ziganshin AU, Ji XD, King BF, Wildman SS, Rychkov A, Yoburn J, Kim H, Mohanram A, Harden TK, Boyer JL, Burnstock G, Jacobson KA. Synthesis and Structure-Activity Relationships of Pyridoxal-6-arylazo-5'-phosphate and Phosphonate Derivatives as P2 Receptor Antagonists. Drug Development Research. 45: 52-66. PMID 22922976 DOI: 10.1002/(Sici)1098-2299(199810)45:2<52::Aid-Ddr2>3.0.Co;2-V |
0.628 |
|
1998 |
Boyer JL, Mohanram A, Camaioni E, Jacobson KA, Harden TK. Competitive and selective antagonism of P2Y1 receptors by N6-methyl 2'-deoxyadenosine 3',5'-bisphosphate. British Journal of Pharmacology. 124: 1-3. PMID 9630335 DOI: 10.1038/Sj.Bjp.0701837 |
0.537 |
|
1998 |
Camaioni E, Costanzi S, Vittori S, Volpini R, Klotz KN, Cristalli G. New substituted 9-alkylpurines as adenosine receptor ligands. Bioorganic & Medicinal Chemistry. 6: 523-33. PMID 9629466 DOI: 10.1016/S0968-0896(98)00007-8 |
0.654 |
|
1998 |
Moro S, Guo D, Camaioni E, Boyer JL, Harden TK, Jacobson KA. Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites. Journal of Medicinal Chemistry. 41: 1456-66. PMID 9554879 DOI: 10.1021/Jm970684U |
0.643 |
|
1998 |
Camaioni E, Di Francesco E, Vittori S, Volpini R, Cristalli G. Adenosine receptor agonists: synthesis and biological evaluation of the diastereoisomers of 2-(3-hydroxy-3-phenyl-1-propyn-1-yl)NECA. Bioorganic & Medicinal Chemistry. 5: 2267-75. PMID 9459024 DOI: 10.1016/S0968-0896(97)00172-7 |
0.396 |
|
1998 |
Camaioni E, Boyer JL, Mohanram A, Harden TK, Jacobson KA. Deoxyadenosine bisphosphate derivatives as potent antagonists at P2Y1 receptors. Journal of Medicinal Chemistry. 41: 183-90. PMID 9457242 DOI: 10.1021/jm970433l |
0.507 |
|
1998 |
Volpini R, Camaioni E, Vittori S, Barboni L, Lambertucci C, Cristalli G. Synthesis of New Nucleosides by coupling of chloropurines with 2- and 3-deoxy derivatives ofN-methyl-D-ribofuranuronamide Helvetica Chimica Acta. 81: 145-152. DOI: 10.1002/Hlca.19980810113 |
0.315 |
|
1998 |
Volpini R, Camaioni E, Costanzi S, Vittori S, Cristalli G. Synthesis of New 3′-Deoxyribonucleosides Employing the Acid-Catalyzed Fusion Method Helvetica Chimica Acta. 81: 2326-2331. DOI: 10.1002/(Sici)1522-2675(19981216)81:12<2326::Aid-Hlca2326>3.0.Co;2-4 |
0.579 |
|
1998 |
Cristalli G, Camaioni E, Costanzi S, Vittori S, Volpini R, Klotz K. Characterization of potent ligands at human recombinant adenosine receptors Drug Development Research. 45: 176-181. DOI: 10.1002/(Sici)1098-2299(199811/12)45:3/4<176::Aid-Ddr14>3.0.Co;2-G |
0.626 |
|
1997 |
Cristalli G, Camaioni E, Di Francesco E, Eleuteri A, Vittori S, Volpini R. Potent and Selective Ligands for Adenosine Binding Sites Nucleosides and Nucleotides. 16: 1379-1388. DOI: 10.1080/07328319708006189 |
0.374 |
|
1996 |
Vittori S, Camaioni E, Di Francesco E, Volpini R, Monopoli A, Dionisotti S, Ongini E, Cristalli G. 2-alkenyl and 2-alkyl derivatives of adenosine and adenosine-5'-N-ethyluronamide: different affinity and selectivity of E- and Z-diastereomers at A2A adenosine receptors. Journal of Medicinal Chemistry. 39: 4211-7. PMID 8863798 DOI: 10.1021/Jm960376G |
0.45 |
|
1996 |
Camaioni E, Di Francesco E, Volpini R, Vittori S, Cristalli G. Unexpected synthesis of acyclic adenine nucleosides Collection of Czechoslovak Chemical Communications. 61: 154-155. DOI: 10.1135/Cccc1996S154 |
0.308 |
|
1996 |
Volpini R, Camaioni E, Di Francesco E, Vittori S, Fein T, Schwabe U, Cristalli G. Synthesis and biological activity of 3'-deoxy derivative of adenosine (5'-N-methylcarboxamide) (MECA) Collection of Czechoslovak Chemical Communications. 61: 33-37. DOI: 10.1135/Cccc1996S033 |
0.358 |
|
1996 |
Cristalli G, Volpini R, Vittori S, Camaioni E, Rafaiani G, Potenza S, Vita A. Diazepinone Nucleosides as Inhibitors of Cytidine Deaminase. Nucleosides and Nucleotides. 15: 1567-1580. DOI: 10.1080/07328319608002457 |
0.367 |
|
1996 |
Cristalli G, Camaioni E, Francesco ED, Vittori S, Volpini R. Chemical and pharmacological profile of selective adenosine receptor agonists Pharmacochemistry Library. 24: 165-180. DOI: 10.1016/S0165-7208(96)80014-6 |
0.458 |
|
1995 |
Cristalli G, Camaioni E, Vittori S, Volpini R, Borea PA, Conti A, Dionisotti S, Ongini E, Monopoli A. 2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists. Journal of Medicinal Chemistry. 38: 1462-72. PMID 7739005 DOI: 10.1021/Jm00009A007 |
0.465 |
|
1995 |
Cristalli G, Vittori S, Eleuteri A, Volpini R, Camaioni E, Lupidi G, Mahmood N, Bevilacqua F, Palù G. Synthesis and biological evaluation of N6-cycloalkyl derivatives of 1-deazaadenine nucleosides: a new class of anti-human immunodeficiency virus agents. Journal of Medicinal Chemistry. 38: 4019-25. PMID 7562937 DOI: 10.1021/Jm00020A017 |
0.38 |
|
1995 |
Vittori S, Volpini R, Camaioni E, Palúg G, Cristalli G. Inhibitory Effects of 1-Deazaadenosine Analogues on HIV Replication and Adenosine Deaminase Nucleosides, Nucleotides and Nucleic Acids. 14: 603-606. DOI: 10.1080/15257779508012435 |
0.328 |
|
1995 |
Cristalli G, Camaioni E, Vittori S, Volpini R. Platelet Aggregation Inhibitory Activity of Selective A2 Adenosine Receptor Agonists Nucleosides, Nucleotides and Nucleic Acids. 14: 449-453. DOI: 10.1080/15257779508012404 |
0.422 |
|
1994 |
Cristalli G, Eleuteri A, Volpini R, Vittori S, Camaioni E, Lupidi G. Adenosine deaminase inhibitors: synthesis and structure-activity relationships of 2-hydroxy-3-nonyl derivatives of azoles. Journal of Medicinal Chemistry. 37: 201-5. PMID 8289197 DOI: 10.1021/Jm00027A026 |
0.432 |
|
1994 |
Cristalli G, Volpini R, Vittori S, Camaioni E, Monopoli A, Conti A, Dionisotti S, Zocchi C, Ongini E. 2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation. Journal of Medicinal Chemistry. 37: 1720-6. PMID 8201607 DOI: 10.1021/Jm00037A024 |
0.43 |
|
1994 |
Cristalli G, Vittori S, Eleuteri A, Volpini R, Camaioni E, Lupidi G. Synthesis of 2′-Deoxyribonucleoside Derivatives of 1-Deazapurine Nucleosides and Nucleotides. 13: 835-848. DOI: 10.1080/15257779408013282 |
0.384 |
|
1993 |
Cristalli G, Vittori S, Eleuteri A, Volpini R, Cola D, Camaioni E, Gariboldi PV, Lupidi G. Synthesis of 1, 7-Dideazapurine Ribonucleosides and Deoxyribonucleosides Nucleosides and Nucleotides. 12: 39-53. DOI: 10.1080/07328319308016193 |
0.374 |
|
1993 |
Cristalli G, Eleuteri A, Vittori S, Volpini R, Camaioni E, Lupidi G. Adenosine deaminase inhibitors: Structure-activity relationships in 1-deazaadenosine and erythro-9-(2-hydroxy-3-nonyl)adenine analogues Drug Development Research. 28: 253-258. DOI: 10.1002/Ddr.430280311 |
0.431 |
|
Show low-probability matches. |